Revvity Inc. $RVTY Holdings Raised by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio increased its stake in Revvity Inc. (NYSE:RVTY) by 33.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 98,237 shares of the company’s stock after purchasing an additional 24,591 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Revvity were worth $8,607,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of RVTY. Ascentis Independent Advisors acquired a new position in Revvity during the 1st quarter valued at about $29,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Revvity in the 2nd quarter worth approximately $32,000. Cromwell Holdings LLC lifted its stake in shares of Revvity by 141.4% in the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after acquiring an additional 198 shares during the period. MUFG Securities EMEA plc bought a new position in shares of Revvity in the second quarter valued at approximately $34,000. Finally, SJS Investment Consulting Inc. boosted its holdings in shares of Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock valued at $47,000 after acquiring an additional 521 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Down 2.2%

NYSE RVTY opened at $108.04 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The company’s 50 day simple moving average is $105.15 and its 200 day simple moving average is $99.61. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The company has a market capitalization of $12.05 billion, a P/E ratio of 51.69, a PEG ratio of 2.17 and a beta of 1.09.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. The firm had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the firm posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities research analysts expect that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio is 13.40%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Barclays boosted their target price on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Sanford C. Bernstein initiated coverage on Revvity in a research note on Friday, June 26th. They set a “market perform” rating and a $115.00 price target for the company. Stifel Nicolaus lowered their price target on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. Weiss Ratings raised Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. Finally, TD Cowen reissued a “buy” rating on shares of Revvity in a research note on Wednesday, July 15th. Four research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $108.92.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.